Drawing for ASTRAZENECA

USPTO serial 75671831

ASTRAZENECA

Reviewed by CopyMark Law Group

Reg. 3102504Status 800Renewal
Filing date
Status date
Registration date
Jun 13, 2006
Examiner
LE, MARGARET
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with ASTRAZENECA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cara M. Kearney

Cara M. Kearney AstraZeneca Pharmaceuticals LP1800 Concord Pike, A2CWilmington, DE 19850-5437United States

Goods and services

ClassDescriptionStatusFirst use
001[ Housemark for chemicals used in industry, science, agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry ]SECTION 8 - CANCELLED—
002[ Housemark for colorants ]SECTION 8 - CANCELLED—
009[ Housemark for computer programmes]SECTION 8 - CANCELLED—
010[ Housemark for surgical and medical instruments ]SECTION 8 - CANCELLED—
029[ Housemark for prepared and processed protein and myco-protein for human consumption ]SECTION 8 - CANCELLED—
041[ Arranging and conducting educational conferences in the field of pharmaceuticals; arranging and conducting symposia in the field of pharmaceuticals ]SECTION 8 - CANCELLED—
042Diagnostic testing and analysis of pharmaceutical products; advisory services relating to healthcare; consultant services relating to health care; all relating to pharmaceutical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 22, 2025NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Oct 22, 2025RNL2REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Oct 22, 202589AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Oct 22, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 2, 2025E89RTEAS SECTION 8 & 9 RECEIVED—
Jun 13, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Mar 13, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 13, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 13, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 13, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 13, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 22, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 22, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 22, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 22, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 22, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 22, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 7, 2015NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Aug 7, 2015RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Aug 7, 201589AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Aug 6, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 15, 2015E89RTEAS SECTION 8 & 9 RECEIVED—
Jun 13, 2015REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Mar 30, 2012NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 30, 2012C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 30, 2012APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 28, 2012E815TEAS SECTION 8 & 15 RECEIVED—
Jun 13, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 2, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 21, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 2006NPUBNOTICE OF PUBLICATION—
Feb 7, 2006AMPBAMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED—
Dec 19, 2005ADBS1(B) BASIS DELETED; NEW BASIS REQUESTED—
Dec 16, 2005PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Nov 8, 2005IUCNNOTICE OF ALLOWANCE CANCELLED—
Nov 8, 2005PDCBPETITION TO DIRECTOR - CHANGE BASIS - RECEIVED—
Nov 8, 2005MAILPAPER RECEIVED—
May 10, 2005EX5GSOU EXTENSION 5 GRANTED—
May 10, 2005EXT5SOU EXTENSION 5 FILED—
May 10, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 18, 2005CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 3, 2004EX4GSOU EXTENSION 4 GRANTED—
Nov 3, 2004EXT4SOU EXTENSION 4 FILED—
Nov 3, 2004MAILPAPER RECEIVED—
May 19, 2004CFITCASE FILE IN TICRS—
May 12, 2004EX3GSOU EXTENSION 3 GRANTED—
May 12, 2004EXT3SOU EXTENSION 3 FILED—
May 12, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 12, 2003EX2GSOU EXTENSION 2 GRANTED—
Nov 12, 2003EXT2SOU EXTENSION 2 FILED—
Nov 12, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 4, 2003EX1GSOU EXTENSION 1 GRANTED—
May 12, 2003EXT1SOU EXTENSION 1 FILED—
May 9, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 12, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 12, 2002ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 28, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 8, 2002NPUBNOTICE OF PUBLICATION—
Jan 15, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 15, 2002ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jan 11, 2002DOCKASSIGNED TO EXAMINER—
Jul 23, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 19, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 6, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 30, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 28, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 2, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 9, 1999UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
Aug 2, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 2, 1999DOCKASSIGNED TO EXAMINER—
Jul 6, 1999DOCKASSIGNED TO EXAMINER—
Jun 28, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance